| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/17/2001 | DE19952957A1 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 05/17/2001 | DE19952956A1 Verfahren zur Verbindung von molekularen Substanzen A method for connection of molecular substances |
| 05/17/2001 | DE10035098A1 Composition for treating heart disease, e.g. hypertension, comprises peptide that mimics the alpha1 interaction domain or compound that increases myosin phosphorylation |
| 05/17/2001 | DE10019473A1 Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden Polypeptide tag's for the detection and purification of polypeptides |
| 05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2404763A1 Mutated il-13 molecules and their uses |
| 05/17/2001 | CA2399371A1 Animal collagens and gelatins |
| 05/17/2001 | CA2396626A1 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | CA2391469A1 Large scale comparative protein structure modeling |
| 05/17/2001 | CA2391421A1 Compositions and methods for modifying an immune response against tropomyosin |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391226A1 Reduced side-effect hemoglobin compositions |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390740A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390719A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | CA2390491A1 Crib protein zmse1 |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2390011A1 Methods and compositions comprising renilla gfp |
| 05/17/2001 | CA2389841A1 Novel nucleic acid molecules encoding cyclised amino acid sequences |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389722A1 15 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389524A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2389041A1 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388829A1 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2 |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388019A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2386866A1 Tumor suppressor molecules and methods of use |
| 05/17/2001 | CA2378086A1 Methods and compositions for peptide synthesis |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099760A1 Bacillus thuringiensis Cry1Ia-Cry1Ba hybrid toxins |
| 05/16/2001 | EP1099758A2 Method and host cells for producing two-chain relaxin polypeptide |
| 05/16/2001 | EP1099757A1 Process for the determination of CTp11 and for determining whether a tumor sample has metatastic potential |
| 05/16/2001 | EP1099708A1 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| 05/16/2001 | EP1099707A2 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 05/16/2001 | EP1099693A1 Radiolabelled peptide compounds |
| 05/16/2001 | EP1098987A1 Method for transformation of animal cells |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098980A2 $i(STREPTOCOCCUS SUIS) VACCINES AND DIAGNOSTIC TESTS |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098977A2 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 05/16/2001 | EP1098976A2 Androgen receptor coactivators |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098973A1 Human lcb kinase 1 |
| 05/16/2001 | EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna |
| 05/16/2001 | EP1098971A2 Myotilin, an actin-organizing protein |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098961A1 Interferon inducing genetically engineered attenuated viruses |
| 05/16/2001 | EP1098910A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 05/16/2001 | EP1098907A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 05/16/2001 | EP1098906A1 Peptide analogues of pacap |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1098902A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 05/16/2001 | EP1098664A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 05/16/2001 | EP1011328A4 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 05/16/2001 | EP0994948B1 Tgf beta rii receptor nucleic sequence, coded peptide, and uses |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | EP0753009B1 Malaria peptides |
| 05/16/2001 | CN1295668A Methods and compositions for diagnosis of hepatoma |
| 05/16/2001 | CN1295623A Self-replicating vector for DNA immunication against HIV |
| 05/16/2001 | CN1295622A Promoter inductible in plants, sequence incorporating same and resulting product |
| 05/16/2001 | CN1295620A Protein expression in baculovirus vector expression system |
| 05/16/2001 | CN1295618A Porcing reproductive and respiratory syndrome oral vaccine production in plants |
| 05/16/2001 | CN1295617A Variants of angiogenic factor vascular endothelial cell growth factor: VEGF |
| 05/16/2001 | CN1295616A Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 05/16/2001 | CN1295615A Human p51 genes and gene products thereof |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295612A Mutant herpes simplex viruses and uses thereoe |
| 05/16/2001 | CN1295580A Method for producing mouse and haman endogenous vascular formation inhibition factor |
| 05/16/2001 | CN1295579A Therapeutic uses of keratinocyte growth factor-2 |
| 05/16/2001 | CN1295515A Bioriented polyethylene film with high water vapor transmission rate |
| 05/16/2001 | CN1295482A Antagonists of the inflammatory mediator oncostatin M (OSM) |
| 05/16/2001 | CN1295129A Method of producing human insulin by utilizing transgenosis tomato |
| 05/16/2001 | CN1295081A Human tumor related nucleoprotein 24 and its code sequence |
| 05/16/2001 | CN1295080A Method of extracting phycocyanin from spirulina |
| 05/16/2001 | CN1065916C Polypeptides relating biology synthetic cobalamins and/or cobamides, coding DNA sequence of polypeptides, process for preparing them and use |
| 05/16/2001 | CN1065912C Genetically engineered attenuated viruses |
| 05/16/2001 | CN1065875C Fibrillating cell growth factor-2 and analogue and its production method and use |
| 05/16/2001 | CN1065864C Aylucone isoflavone enriched regetable protein whey, whey protein, and process for producing same |
| 05/16/2001 | CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule |
| 05/16/2001 | CA2290211A1 Method for purifying fsh |
| 05/15/2001 | US6232528 Disease resistance in vitis |
| 05/15/2001 | US6232527 Structure specific endonuclease in dna replication and nucleotide excision repair reactions for gene targeting and production of male sterile plants |
| 05/15/2001 | US6232525 Mutant plants and uses therefor |
| 05/15/2001 | US6232523 To study tumor progresssion in vertebrates; stably transformed tumor cell line transfected with expression vector nucleotide sequence under control of viral promoter; continued expression through cell line proliferation |